New drug aims to halt early blood cancer before it starts
NCT ID NCT03236428
First seen Mar 29, 2026 · Last updated Apr 24, 2026 · Updated 5 times
Summary
This study tests a drug called daratumumab in people with two early blood conditions that can lead to multiple myeloma. The goal is to see if the drug can reduce or control the abnormal cells, preventing progression to active cancer. Participants receive treatment for up to 20 cycles, and researchers track how well the disease responds.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMOLDERING MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
Colorado Blood Cancer Institute
Denver, Colorado, 80218, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Karmanos Cancer Insitute
Detroit, Michigan, 48201, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02214, United States
-
Pacific Cancer Care
Monterey, California, 93940, United States
Conditions
Explore the condition pages connected to this study.